Dataset: Re-analysis by microarray using cDNA target of samples from psoriasis patients enrolled in an etanercept trial
cDNA and cRNA hybridization technologies have different, probe-specific sensitivities. We used samples from an etanercept trial...
cDNA and cRNA hybridization technologies have different, probe-specific sensitivities. We used samples from an etanercept trial (GSE11903) to explore in a real-life setting the uniqueness of each platform. We obtained total RNA for a subset of the samples in GSE11903 from Jim Krueger and generated expression profiles using labeled cDNA target. From 14 patients, available base-line lesional and non-lesional skin biopsy pairs as well as post-dose samples were analyzed. All the samples were run on Affymetrix HU133 Plus 2.0 microarrays.
- Species:
- human
- Samples:
- 81
- Source:
- E-GEOD-41663
- Updated:
- Dec.12, 2014
- Registered:
- Sep.19, 2014
Factors:
(via ArrayExpress)
Sample | TISSUE TYPE | TIME |
---|---|---|
GSM1021296 | Non-lesional skin | Pre-dose |
GSM1021297 | Lesional skin | Pre-dose |
GSM1021298 | Lesional skin | Week1_etanercept |
GSM1021299 | Lesional skin | Week2_etanercept |
GSM1021300 | Lesional skin | Week4_etanercept |
GSM1021296 | Non-lesional skin | Pre-dose |
GSM1021297 | Lesional skin | Pre-dose |
GSM1021298 | Lesional skin | Week1_etanercept |
GSM1021299 | Lesional skin | Week2_etanercept |
GSM1021300 | Lesional skin | Week4_etanercept |
GSM1021296 | Non-lesional skin | Pre-dose |
GSM1021297 | Lesional skin | Pre-dose |
GSM1021298 | Lesional skin | Week1_etanercept |
GSM1021299 | Lesional skin | Week2_etanercept |
GSM1021300 | Lesional skin | Week4_etanercept |
GSM1021296 | Non-lesional skin | Pre-dose |
GSM1021297 | Lesional skin | Pre-dose |
GSM1021298 | Lesional skin | Week1_etanercept |
GSM1021299 | Lesional skin | Week2_etanercept |
GSM1021300 | Lesional skin | Week4_etanercept |
GSM1021296 | Non-lesional skin | Pre-dose |
GSM1021297 | Lesional skin | Pre-dose |
GSM1021298 | Lesional skin | Week1_etanercept |
GSM1021299 | Lesional skin | Week2_etanercept |
GSM1021300 | Lesional skin | Week4_etanercept |
GSM1021296 | Non-lesional skin | Pre-dose |
GSM1021297 | Lesional skin | Pre-dose |
GSM1021298 | Lesional skin | Week1_etanercept |
GSM1021299 | Lesional skin | Week2_etanercept |
GSM1021300 | Lesional skin | Week4_etanercept |
GSM1021296 | Non-lesional skin | Pre-dose |
GSM1021297 | Lesional skin | Pre-dose |
GSM1021298 | Lesional skin | Week1_etanercept |
GSM1021299 | Lesional skin | Week2_etanercept |
GSM1021300 | Lesional skin | Week4_etanercept |
GSM102133 | Lesional skin | Week12_etanercept |
GSM1021296 | Non-lesional skin | Pre-dose |
GSM1021297 | Lesional skin | Pre-dose |
GSM1021298 | Lesional skin | Week1_etanercept |
GSM1021299 | Lesional skin | Week2_etanercept |
GSM1021300 | Lesional skin | Week4_etanercept |
GSM102133 | Lesional skin | Week12_etanercept |
GSM1021296 | Non-lesional skin | Pre-dose |
GSM1021297 | Lesional skin | Pre-dose |
GSM1021298 | Lesional skin | Week1_etanercept |
GSM1021299 | Lesional skin | Week2_etanercept |
GSM1021300 | Lesional skin | Week4_etanercept |
GSM102133 | Lesional skin | Week12_etanercept |
GSM1021296 | Non-lesional skin | Pre-dose |
GSM1021297 | Lesional skin | Pre-dose |
GSM1021298 | Lesional skin | Week1_etanercept |
GSM1021299 | Lesional skin | Week2_etanercept |
GSM1021300 | Lesional skin | Week4_etanercept |
GSM102133 | Lesional skin | Week12_etanercept |
GSM1021296 | Non-lesional skin | Pre-dose |
GSM1021297 | Lesional skin | Pre-dose |
GSM1021298 | Lesional skin | Week1_etanercept |
GSM1021299 | Lesional skin | Week2_etanercept |
GSM1021296 | Non-lesional skin | Pre-dose |
GSM1021297 | Lesional skin | Pre-dose |
GSM1021298 | Lesional skin | Week1_etanercept |
GSM1021299 | Lesional skin | Week2_etanercept |
GSM102133 | Lesional skin | Week12_etanercept |
GSM1021296 | Non-lesional skin | Pre-dose |
GSM1021297 | Lesional skin | Pre-dose |
GSM1021298 | Lesional skin | Week1_etanercept |
GSM1021299 | Lesional skin | Week2_etanercept |
GSM1021300 | Lesional skin | Week4_etanercept |
GSM102133 | Lesional skin | Week12_etanercept |
GSM1021296 | Non-lesional skin | Pre-dose |
GSM1021297 | Lesional skin | Pre-dose |
GSM1021298 | Lesional skin | Week1_etanercept |
GSM1021299 | Lesional skin | Week2_etanercept |
GSM1021300 | Lesional skin | Week4_etanercept |
GSM102133 | Lesional skin | Week12_etanercept |
GSM1021296 | Non-lesional skin | Pre-dose |
GSM1021297 | Lesional skin | Pre-dose |
GSM1021298 | Lesional skin | Week1_etanercept |
GSM1021299 | Lesional skin | Week2_etanercept |
GSM1021300 | Lesional skin | Week4_etanercept |
GSM102133 | Lesional skin | Week12_etanercept |